DAJIAWEIKANG

Zhitong · Jun 9 at 05:45 AM

DAJIAWEIKANG: The share reduction plan of the concerted parties of the controlling shareholder expired without any shares being reduced

Zhitong · Jun 1 at 03:26 AM

DAJIAWEIKANG's subsidiary has obtained the drug registration certificate for Azithromycin dry suspension

e公司 · Apr 27 at 07:23 AM

DAJIAWEIKANG Q1 report: Net profit surged by 89.7%, driven by both professional pharmacies and the pharmaceutical industry

Zhitong · Feb 6 at 05:18 AM

DAJIAWEIKANG: Shareholder Changsha Tongjia plans to reduce holdings by no more than 3%

Zhitong · Jan 26 at 07:43 PM

Most of the biotechnology vaccine sector has retreated, with SSSW and DAJIAWEIKANG falling over 10%

Zhitong · Jan 26 at 06:12 AM

DAJIAWEIKANG expects a pre-loss, with an estimated net loss attributable to the parent company of 250 million to 300 million yuan for the fiscal year 2025